What Happened?
Cambridge, MA-based Disc Medicine Appointed Jenny Klinger as Head of Financial Planning and Analysis
About the Company
Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. We are building a portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease.
About the Person
Jenny Klinger is Head of Financial Planning and Analysis at Disc Medicine. Previously, Jenny held various senior HR leadership roles in the industry.
Info Source
News
Short Profile